Webinar

Post-ESMO Webinar with Dr. Dummer: Skin Cancer News 2020

Webinar Recording Available! Click HERE

Presented by Professor Reinhard Dummer, Professor of the University of Zurich and Vice-Chairman of the Department of Dermatology in the University Hospital of Zürich, Switzerland, this webinar reviews late breaking news, key takeaways, clinical data and other updates presented at the European Society for Medical Oncology (ESMO) Virtual Congress Annual Meeting September-October 2020. Dr. Dummer shares his key insights into what the landscape of melanoma and non-melanoma skin cancer treatment looks like for the near future. Watch until the end to see Dr. Dummer and Kathy Barnard discuss hope and survivorship in melanoma skin cancer.

***

Prof. Reinhard Dummer, MD
Vice-Chairman, Department of Dermatology
University Hospital of Zürich, Switzerland

Professor Reinhard Dummer is Professor of the University of Zurich and Vice-Chairman of the Department of Dermatology in the University Hospital of Zürich, Switzerland and is a key thought leader in worldwide cutaneous oncology. Currently he is heading of the Skin Cancer Unit and the Clinical Trial Unit of the Department of Dermatology. Professor Dummer began his medical education in haematology and oncology before successfully completing his dermatology residency in Würzburg, Germany, and Zürich in 1992.

He is Board Certified in allergology, clinical immunology, dermatology and dermatopathology.

Professor Dummer’s principal research interests are molecular biology, immunology and immunotherapy of cutaneous malignancies, including cutaneous lymphomas and melanomas. He has published more than 741 papers with a cumulative impact factor of more than 6372. He w as past-president of the Melanoma Project Group of the Swiss Institute for Applied Cancer Research since 1999 -2016, is a member of German National Academy of Sciences (Leopoldina) and is past board member of the Society for Melanoma Research and past President of the International Society for Cutaneous Lymphomas.

He is a founding and board member of the European Association of Dermato-Oncology (EADO), ESMO, URPP and past President of the European Society for Dermatological Research (ESDR).

In the last 20 years, he has developed a leading skin cancer center. This center offers best medical care, a network of clinical trials reaching from phase I to phase III. His contributions are acknowledge in many publications in outstanding journals such as New England Journal of Medicine, Lancet, Lancet Oncology, Press etc. Locally he is intensify cooperation with basic research group at the University and the federal University (ETH). This has resulted in translation work improving our understanding of cutaneous malignancies.

To view the webinar recording please CLICK HERE

SYSF Webinar – Melanoma Treatment FAQs: Do’s, Don’ts, and How to Manage Side Effects

Recording available!

Join us to hear the latest updates on current immunotherapy and targeted therapy treatments for melanoma and non-melanoma skin cancers in Canada.

Dr. Smylie and Dr. Iafolla will hold a panel discussion on recommended dietary and lifestyle habits while on treatment, as well as managing toxicities from fever and pneumonitis to dermatologic complications from immune checkpoint inhibitors.

Presenters:

Dr. Michael Smylie, Medical Oncologist, Cross Cancer Institute, Professor, Department of Oncology, University of Alberta, Edmonton
Dr. Marco Iafolla, MD, MSc, FRCPC, Assistant Professor, University of Toronto, Medical Oncologist, Genitourinary and Cutaneous Site Lead, William Osler HS

Click HERE to view the recording!

SYSF Webinar! MANAGEMENT OF MELANOMA TREATMENT in the COVID-19 Setting

Recording available!

MANAGEMENT OF MELANOMA TREATMENT in the COVID-19 Setting

Hear a panel discussion from the Surgical and Medical Oncology perspective on how melanoma treatment has been impacted by the COVID-19 pandemic.

Focus:

Treatment side effects
Common side effects of targeted therapy and immunotherapies in melanoma
How side effects may overlap with COVID-19 symptoms
What to watch for
How to effectively manage key common side effects of targeted therapy and immunotherapies

Presenters:
Nicole Look Hong, MD, M.Sc., Surgeon, Sunnybrook Health Sciences Centre
Marcus Butler, MD, Medical Oncology, Princess Margaret Cancer Centre
Massey Nematollahi, RN, CNS, OCN, CON, Immuno-Oncology Clinical Nurse Specialist, William Osler Health System

Facilitator:
Kathy Barnard, melanoma survivor, and Founder, Save Your Skin Foundation

Click HERE to listen to the recording

To view the educational video developed by the team at William Osler Health System please Click HERE

To learn more about the COVID-19 Cancer Patient Support Hub and resources mentioned by Kathy, please visit this website: https://covid19oncologyresources.ca/

SYSF Webinar: Ocular Melanoma

Ocular Melanoma – Innovative Treatments and Beyond

With Presenters:

Dr. Marcus Butler, Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Dr. Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, California

Nigel Deacon, Ocular Melanoma Survivor/Patient, British Columbia, Canada

This webinar provides an update on the landscape of metastatic ocular melanoma treatment in Canada and the United States. Dr. Hamid and Dr. Butler share their knowledge of current practices and care pathways, identifying the most pressing needs for patients. They also discuss innovative treatment options such as IMCgp100, as well as clinical trials available to Canadian patients with ocular or uveal melanoma. Nigel Deacon shares his experience with this rare cancer; Kathy Barnard facilitating.

Missed the webinar? Listen to a recording of the presentation here, or watch it on our YouTube channel here.

SYSF Webinar: Treatment Options for Melanoma Patients in the Adjuvant Setting

Join us for this free webinar, which reviews the latest news and clinical data related to melanoma treatment in the adjuvant setting, as presented in the 2018 conference season.

‘Adjuvant’ refers to patients with a stage II or stage III diagnosis. The majority of adjuvant patients typically undergo surgery to have their tumour(s) removed, but are not given immunotherapy or targeted therapy to prevent recurrence of the disease despite a known high-risk of relapse and mortality. Melanoma is an aggressive cancer; stage III melanoma means the cancer has spread from skin cells into the lymphatic system, and poses a dangerous risk for spread to organs, which is what depicts a stage IV diagnosis.

Dr. Claveau shares his key insights into what the landscape of adjuvant melanoma immuno-oncology treatment looks like for the near future in Canada. Dr. Adrian Gunaratne details the science behind targeted therapy and what is coming for Canadian melanoma patients in the adjuvant setting with a BRAF positive mutation. The discussion continues with a patient and a caregiver both having had treatment access challenges in the adjuvant melanoma setting, and how their experiences impacted their lives and that of their families.

Presenters:

Dr. Joel Claveau, Medical Oncologist, Hotel-Dieu de Quebec, Université Laval, Quebec City, QC
Adrian Gunaratne, PhD, Medical Science Liaison – Solid Tumors, Novartis Pharmaceuticals Canada
Natalie Richardson, Adjuvant Melanoma Patient, Managing Director, Save Your Skin Foundation
Eyyub Hajiyev, Caregiver to a loved one recently diagnosed with melanoma in the adjuvant setting

pre-DPPS Webinar – Health Care Systems in Canada: Where We Are Now

In advance of the upcoming Drug Pricing Policy Summit in Toronto in November, you are invited to join the webinar: Health Care Systems in Canada: Where We Are Now on Wednesday, October 24^th from 12:00 – 1:00 PM ET.

This webinar will provide a broad overview of Canada’s drug approval process: Health Canada, pCPA, CADTH and PMPRB with the objective of updating participants on each of the organization’s roles and current initiatives in making drugs available to Canadians.

This is a primer for participants attending the November 13-14 2018 Drug Pricing Policy Summit: Patients Redefining Health Care and for others who would like to have a review of these systems for their interest.

To register for this free webinar, please CLICK HERE.

Melanoma Patient Support Group Webinars

All patients, survivors, family members, and caregivers are invited to join these informal monthly webinars to connect with other patients and survivors across Canada. Join one or all three:
Thurs, February 1, 2018
Thurs, March 1, 2018
Thurs, April 5, 2018

5pm PST | 8pm EST

We know the importance of having a good support network during difficult times. This is why we decided to organize a recurring support group by Webinar. Although melanoma patients and survivors are scattered all over Canada, these webinars will allow them to talk to others going through similar experiences from the comfort of their own home. Founder Kathy Barnard will be in attendance, along with other members of the SYSF team. Whether you’re a patient or a caregiver, we hope that you will take part in this virtual discussion around melanoma, treatments, and hope.

CLICK HERE TO REGISTER

Within 48 hours of registering for this webinar, you will receive an email from natalie@saveyourskin.ca providing you with the link and dial-in details for this group call in gotoMeeting. You will be able to choose if you wish to share your webcam with all participants, or participate in call-in mode only.

Thank you, and hope to chat with you soon!

Webinar: About BioSimilars

As a kick-off to our 2018 webinar series, Save Your Skin Foundation presents:

About Biosimilars: What We Know and What We Want to Know

Friday, January 19, 2018 at 1pm – 2pm EST | 10am-11am PST

Presenters: Louise Binder, SYSF Health Policy, Cathy Parker, Director Policy and International Collaboration – Health Canada, and Helen Mai, Policy and Strategy Advisor, CADTH.

This webinar will be a panel discussion on Biosimilars in oncology, the approval process, and the potential policy position for oncology drug reimbursement. Discussion Points will include Health Canada’s review and approval for sale, CADTH’S role in this area and their involvement with pCPA, and potential policy objectives and position for oncology drug reimbursement.

Updated January 23, 2018:

Missed the webinar? Listen to a recording of the presentation here, or view it on our youTube channel here. Also please click here for a page of Resources regarding Biosimilars.

Holiday Melanoma Patient Support Webinar

Join our Holiday Patient Support Webinar on Thursday, Dec 28, 2017 at 1pm PST | 4pm EST.

All patients, family members, and caregivers are invited to join this informal, free webinar to share and connect with patients and survivors across Canada.

Click HERE to register

Save Your Skin Foundation knows the importance of having a good support network during difficult times. This is why we had the idea to organize a support group by Webinar. Since we are scattered all over Canada, we thought it would be a good idea to be able to talk to people and hear them, but in the comfort of your own home. Founder Kathy Barnard will be available to discuss, along with other members of the SYSF team. Whether you’re a patient or a caregiver, we hope that you will take part in this virtual discussion around melanoma, treatments, and hope.

Next Webinar December 17: The Drug Evaluation Process – Patient Input Submissions and Responsible Advocacy for New Treatments

This webinar will dive into the process used to evaluate drugs, which concludes with recommendations about whether they should be covered by provincial formularies. In particular, this webinar will look at how patients can engage in the process. Following the presentation, there will be a live Q&A. The presentation will address the following topics:

When and how can patients engage with the drug evaluation process?
What are the best practices to promote the patient’s voice?
Looking ahead: how can we improve patients’ opportunities to engage?

The webinar will be hosted by Bill Dempster of 3Sixty Public Affairs. As CEO of 3Sixty Public Affairs, Bill Dempster helps health charities, businesses and associations understand health policy and effectively engage with governments. He applies a deep business, health policy, legal and government experience to find mutually beneficial solutions to complex problems.

To register

https://attendee.gotowebinar.com/register/1418260419678793473

Post-ESMO Webinar with Dr. Dummer: Skin Cancer News 2020

SYSF Webinar – Melanoma Treatment FAQs: Do’s, Don’ts, and How to Manage Side Effects

Click HERE to view the recording!

SYSF Webinar! MANAGEMENT OF MELANOMA TREATMENT in the COVID-19 Setting

Click HERE to listen to the recording

SYSF Webinar: Ocular Melanoma

SYSF Webinar: Treatment Options for Melanoma Patients in the Adjuvant Setting

pre-DPPS Webinar – Health Care Systems in Canada: Where We Are Now

Melanoma Patient Support Group Webinars

CLICK HERE TO REGISTER

Webinar: About BioSimilars

Holiday Melanoma Patient Support Webinar

Next Webinar December 17: The Drug Evaluation Process – Patient Input Submissions and Responsible Advocacy for New Treatments

Recent Posts

Twitter

Newsletter Signup

Next Webinar December 17: The Drug Evaluation Process – Patient Input Submissions and Responsible Advocacy for New Treatments

Webinar

Recent Posts

Twitter

Newsletter Signup

Follow us on social media!